相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL
Francesco Menzella et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2023)
Omalizumab as monotherapy for food allergy
Stefania Arasi et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness
G. J. Molderings et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Use of biologics in severe food allergies
Alessandro Fiocchi et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis
Stefania Arasi et al.
ITALIAN JOURNAL OF PEDIATRICS (2016)
Omalizumab and the immune system: an overview of preclinical and clinical data
SGO Johansson et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2002)